IM Cannabis (US:IMCC) Prnewswireยท2025-07-11 12:00Core Viewpoint - IM Cannabis Corp. has filed a shelf registration statement with the SEC, allowing the company to offer and sell up to $50 million of its securities, including common shares, warrants, and units, depending on market conditions and capital needs [1][2]. Company Overview - IM Cannabis Corp. is a leading medical cannabis company operating in Israel and Germany, focusing on providing premium cannabis products to medical patients in these significant markets [5]. - The company aims for sustainable and profitable growth by leveraging a data-driven approach and a globally sourced product supply chain [5]. Operations - In Israel, IM Cannabis operates through subsidiaries that import and distribute cannabis, manage medical cannabis retail pharmacies, and utilize online platforms for distribution [6]. - In Germany, the company distributes cannabis to pharmacies through its subsidiary, Adjupharm GmbH, catering to medical cannabis patients [6]. Shelf Registration Details - The shelf registration allows the company to sell securities on a registered basis, with specific terms and prices to be determined at the time of offering [2][3]. - The registration does not obligate the company to sell any specific amount of securities, as future offerings will depend on market conditions and the company's discretion [3].